Medicaid tries new approach with sickle cell: Companies only get paid if costly gene therapies work

Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting friends. It was a contrast to how Cole, 18, spent part of the 2024 holiday season. She was in the hospital—a frequent…

Continue Reading

News Source: medicalxpress.com